Is small cell lung cancer the perfect target for anti-telomerase treatment?

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1649-1651

  Sarvesvaran, Joseph ^a   Going, James J ^a   Milroy, Robert ^b   Kaye, Stanley B ^a   Keith, W Nicol ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b STOBHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDYLTRANSFERASE INHIBITOR; PROTEIN BCL 2; PROTEIN P53; RNA; TELOMERASE;

ARTICLE; CANCER MORTALITY; DRUG TARGETING; GENE THERAPY; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

CARCINOID TUMOR; CARCINOMA, SMALL CELL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032818149     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1649     Document Type: Article

References (16)

1. Sekido, Y., Fong, K.M. and Minna, J.D. (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta, 1378, F21-F59.
2. Boral, A.L., Dessain, S. and Chabner, B.A. (1998) Clinical evaluation of biologically targeted drugs: obstacles and opportunities. Cancer Chemother. Pharmacol., 42, S3-S21.
3. Wang, D.G., Johnston, C.F., Sloan, J.M. and Buchanan, K.D. (1998) Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53. J. Pathol., 184, 247-251.
4. Brambilla, E., Negoescu, A., Gazzeri, S., Lantuejoul, S., Moro, D., Brambilla, C. and Coll, J.L. (1996) Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am. J. Pathol., 149, 1941-1952.
5. Sharma, S., Raymond, E., Soda, H., Sun, D., Hilsenbeck, S.G., Sharma, A., Izbicka, E., Windle, B. and Von Hoff, D.D. (1997) Preclinical and clinical strategies for development of telomerase and telomere inhibitors. Ann. Oncol., 8, 1063-1074.
6. Urquidi, V., Tarin, D. and Goodison, S. (1998) Telomerase in cancer: clinical applications. Ann. Med., 30, 419-430.
7. Zhao, J.Q., Hoare, S.F., McFarlane, R., Muir, S., Parkinson, E.K., Black, D.M. and Keith, W.N. (1998) Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene, 16, 1345-1350.
8. Wan, M.S., Fell, P.L. and Akhtar, S. (1998) Synthetic 2′-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity. Antisense Nucleic Acid Drug Dev., 8, 309-317.
9. Norton, J.C., Piatyszek, M.A., Wright, W.E., Shay, J.W. and Corey, D.R. (1996) Inhibition of human telomerase activity by peptide nucleic acids. Nature Biotechnol., 14, 615-619.
10. Kondo, Y., Kondo, S., Tanaka, Y., Haqqi, T., Barna, B.P. and Cowell, J.K. (1998) Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis. Oncogene, 16, 2243-2248.
11. Kondo, S., Ranaka, Y., Kondo, Y., Hitomi, M., Barnett, G.H., Ishizaka, Y., Liu, J., Haqqi, T., Nishiyama, A., Villeponteau, B., Cowell, J.K. and Barna, B.P. (1998) Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J., 12, 801-811.
12. Kondo, S., Kondo, Y., Li, G., Silverman, R.H. and Cowell, J.K. (1998) Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene. 16, 3323-3330.
13. Glukhov, A.I., Zimnik, O.V., Gordeev, S.A. and Severin, S.E. (1998) Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides. Biochem. Biophys. Res. Commun., 248, 368-371.
14. Feng, J., Funk, W.D., Wang, S.S. et al. (1995) The RNA component of human telomerase. Science, 269, 1236-1241.
15. Soder, A.I., Going, J.J., Kaye, S.B. and Keith, W.N. (1998) Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene, 16, 979-983.
16. Shay, J.W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer, 33, 787-791.